People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Pharmaceuticals, Other Technology, Retailing, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SciSparc Ltd. | — | Pharmaceuticals | Series A | $25.3M | $16.1M | 2019 |
| Rail Vision Ltd. | — | Other Technology | Seed | $9.0M | $18.6M | 2023 |
| Jeffs' Brands Ltd | — | Retailing | Series A | $7.3M | $22.9M | 2024 |
| Clearmind Medicine Inc. | — | Biotechnology | Seed | $2.4M | $15.1M | 2024 |
Oz Adler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Oz Adler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amitay Weiss | 4 | 6 |
| Moshe Revach | 2 | 3 |
| Dr. Adi Zuloff-Shani | 2 | 2 |
| Eric So | 1 | 5 |
| Yehonatan Shachar | 1 | 2 |
| Israel Berenstein | 1 | 2 |
| Asaf Itzhaik | 1 | 2 |
| Stephen Simes | 1 | 2 |
| Liron Carmel | 1 | 2 |
| Alan Rootenberg | 1 | 2 |
| Eli Yoresh | 1 | 2 |
| Zohar Heiblum | 1 | 2 |
| Eliyahu Yoresh | 1 | 2 |
| Ascher Shmulewitz | 1 | 2 |
| Alon Dayan | 1 | 2 |
| Ofer Grisaro | 1 | 1 |
| Mark Cleobury | 1 | 1 |
| Zachi Bar-Yehoshua | 1 | 1 |
| Yossi Daskal | 1 | 1 |
| Maximilian Eichhorn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.